Board Committee table legend

Chair
Member
Committee List
Audit Committee Position
Mitchell Chan  
Chair
Jonathan Goldman, MD
Member
Kevin Lind
Member
Download
Committee List
Compensation Committee Position
Aaron Kantoff
Chair
Rita Jain, MD
Member
Samantha Truex
Member
Download
Committee List
Nominating and Corporate Governance Committee Position
Samantha Truex
Chair
Aaron Kantoff
Member
Gilla Kaplan, PhD
Member
Download
Committee List
Science and Technology Committee Position
Rita Jain, MD
Chair
Jonathan Goldman, MD
Member
Gilla Kaplan, PhD
Member
Download

Mitchell Chan

Jonathan Goldman, MD

Kevin Lind

Mr. Lind is a seasoned biotechnology executive with more than 20 years of leadership experience. He most recently served as President, Chief Executive Officer, and Board Member of Longboard Pharmaceuticals, where he led and transformed the Arena spinout into a leader in neurology and oversaw its $2.6 billion acquisition by H. Lundbeck A/S in 2024. Prior to his time at Longboard, Mr. Lind was Executive Vice President and Chief Financial Officer at Arena Pharmaceuticals, where he played a central role in its turnaround, including lucrative business development partnerships and execution of its spinout of Longboard in 2020. Over the course of his career, Mr. Lind has raised more than a billion dollars in capital to support innovative biotech companies. He began his career in investment banking at Lehman Brothers before joining TPG, where he focused on healthcare investing. In addition to his role with Avalo, Mr. Lind currently serves as Chairman of the Board of Apnimed, Inc. He received a BS from Stanford University in Biological Sciences and an MBA from UCLA Anderson School of Management.

Aaron Kantoff

Rita Jain, MD

Samantha Truex

Samantha Truex

Aaron Kantoff

Gilla Kaplan, PhD

Rita Jain, MD

Jonathan Goldman, MD

Gilla Kaplan, PhD

Governance Documents